Building a competitive and sustainable biotech ecosystem in Europe
Does Europe still have a realistic chance of remaining competitive with the United States and China in biotechnology—and under what
Read more
Research & Innovation
Strengthening Europe’s pharmaceutical sovereignty.
Across the European Union, 2023 and 2024 saw record levels of medicine shortages reported, with 136 medicines running critically short
Read more
The Biotech Act: A blueprint for a strong, resilient, and fair Health Union
How many more patients must we fail before we admit that Europe’s health innovation system is broken? How many more
Read more
Regional biotech ecosystems as engines of Europe’s health sovereignty: from clusters to global competitiveness
As health innovation becomes a strategic arena shaped by geopolitics, Europe’s quest for health sovereignty is unfolding in a far
Read more
Scaling Cell Therapy in Europe: Why the Biotech Act Must Keep Pace with Innovation
Some medical advances treat a disease. A rare few can end it. CAR T-cell therapy belongs to the second kind.
Read more
Clinical Trials at the Heart of EU’s Competitiveness: Delivering on the Promise of the EU Biotech Act
EU’s life sciences sector is at a turning point. While the region continues to generate world-class science, it is increasingly
Read more
Building the future of health in Europe
Europe’s healthcare systems are among our greatest achievements. They are built on a simple promise: that people should receive the
Read more
Europe’s Quest for Health Sovereignty: Building the Next Generation of Biotechnology
Energy system integration in Europe – Decarbonization of the European economy
Read more